Monitoring the Effects of Semaglutide Monitoring the effects of Semaglutide is an essential part of a patients health management, as it allows for the assessment of the medications effectiveness and detection of any potential side effects
Meet the Experts Angela Fitch, MD, is the founder and chief medical officer of knownwell, a weight-inclusive healthcare provider based in Needham, Massachusetts
Currently, it is the phase 3 trial process, which will get FDA approval in early 2026, if the data comes back positive
MOAA (Military Officers Association of America) Weight-Loss Drug Coverage Ends for TRICARE for Life Beneficiaries: Whats Next? Summarizes how the policy affects TRICARE For Life members and offers updates on advocacy efforts
If you're in Texas or Utah and thinking about GLP-1 therapy (or you're already on it and struggling to eat well), we'd love to help